Home
Product List
News
Contact Us
Documents

Product List 

 

Raloxifene Hydrochloride 82640-04-8 Raloxifene HCL Anti Cancer Steroid

Model No.︰82640-04-8
Brand Name︰kafenbio
Country of Origin︰China
Unit Price︰US $ 1 / Gram
Minimum Order︰1 Gram
Share on:

 Total 25 Related Items 
Prev7891011Next

Product Description

Raloxifene Hydrochloride Anti Estrogen Supplements 82640-04-8 Raloxifene HCL Anti Cancer Steroid

 

Basic Info.

Name:Raloxifene hydrochloride 
Synonyms: Raloxifene hcl;Raloxifene hydrochloride;Ly156758;
6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidin;
Keoxifene;Keoxifene hydrochloride;Ly 139481;Akos 92138
CAS: 82640-04-8 
MF: C28H28ClNO4S 
MW: 510.04 
Assay:99%
Standard:USP32
Chemical Properties: Light-Yellow Solid 
Usage: amino acid, nutrient. A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic. 
Packing:1kg/foil bag or as  required


Description:

Raloxifene hydrochloride (HCl) has the empirical formula C28H27NO4SHCl, which corresponds to a molecular weight of 510.05 g/mol. Raloxifene HCl is an off-white to pale-yellow solid that is slightly soluble in water.
SERMs mimic estrogen in some tissues and have anti-estrogen activity in others. Other SERMs, such as Pfizer's lasofoxifene and Wyeth's bazedoxifene are in the later development phases.

Evista (Raloxifene Hydrochloride) is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism).


Usage:

Evista is specifically approved for the treatment and prevention of osteoporosis in postmenopausal women, the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer. Evista is supplied as a 60 mg tablet designed for oral administration. The recommended initial dose of the drug is one 60 mg tablet daily, which may be administered any time of day without regard to meals.

Payment Terms︰Western Union,T/T,Bitcoins,MoneyGram.Alipay.
Product Image


Related Products
Tolnaftate CAS 2398-96-1 Pharmaceutical Raw material
Tolnaftate CAS 2398-96-1 Pharmaceutical Raw material
US $ 1
Raw Material Telmisartan CAS 144701-48-4 for Anti-cancer agent
Raw Material Telmisartan CAS 144701-48-4 for Anti-cancer agent
US $ 1
Melatonin /Melatonine for Nutritional Supplement 73-31-4
Melatonin /Melatonine for Nutritional Supplement 73-31-4
US $ 1
Pharmaceutical Chemicals Isotretinoin Accutane for AcneTreatment
Pharmaceutical Chemicals Isotretinoin Accutane for AcneTreatment
US $ 1

Home  |  Product List  |  News  |  Contact Us  |  Documents  |  Sitemap  |  Mobile Version
  English     简体版     繁體版
Powered by DIYTrade.com
HomeContact UsSitemap